Study Identifies Key Player in Cancer Cell Death Mechanism
Groundbreaking study reveals the role of RTN4 in triggering pyroptosis in cancer cells, offering new possibilities for anticancer immunotherapy.
Understanding how RTN4 influences pyroptosis opens doors to potential cancer treatments that enhance antitumor immunity. Targeting RTN4 for ER remodeling could lead to the development of novel anticancer agents and improve the efficacy of current immunotherapies.
